Safety of long-term lamotrigine in epilepsy

Epilepsia

Volumn 38, Issue 8, 1997, Pages 881-886

  Mackay, F J ^a   Wilton, L V ^a   Pearce, G L ^a   Freemantle, S N ^a   Mann, R D ^a  

^a DRUG SAFETY RESEARCH UNIT   (United Kingdom)

Author keywords

Drug safety; Epilepsy; Lamotrigine; Prescription Event Monitoring; Rash

Indexed keywords

LAMOTRIGINE;

ADULT; ARTICLE; CHILD; COHORT ANALYSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DROWSINESS; DRUG SAFETY; EPILEPSY; FEMALE; HEADACHE; HUMAN; INCIDENCE; LASSITUDE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALAISE; MALE; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RASH; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; VOMITING;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIZZINESS; DRUG ERUPTIONS; DRUG MONITORING; DRUG PRESCRIPTIONS; EPILEPSY; EXANTHEMA; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HEADACHE; HUMANS; MALE; MIDDLE AGED; NAUSEA; PREGNANCY; PREGNANCY COMPLICATIONS; PRESCRIPTIONS, DRUG; RISK FACTORS; STEVENS-JOHNSON SYNDROME; TRIAZINES;

EID: 0030863344     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1997.tb01252.x     Document Type: Article

References (13)

1. Inman WHW. Postmarketing surveillance of adverse drug reactions in general practice; II: Prescription-event monitoring at the University of Southampton. BMJ 1981;282:1216-7.
2. Rawson NSB, Pearce GL, Inman WHW. Prescription-event monitoring: methodology and recent progress. J Clin Epidemiol 1990;43:509-22.
3. Mann RD. Prescription-event monitoring: its role in ensuring new drug safety. Prescriber 1996;7(5):102-4.
4. Wilton LV, Pearce GL, Mann RD. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol 1996;41:277-84.
5. Schmidt D, Kramer G. The new anticonvulsant drugs: implications for avoidance of adverse effects. Drug Safety 1994;11(6):422-31.
6. Brodie MJ, Richens A, Yuen A. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-9.
7. Drug treatment of epilepsy. Drug Ther Bull 1994;32(6):45-8.
8. ABPI data sheet compendium 1995/6. Datapharm Publications Limited, pp 1933-5.
9. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333(24):1600-7.
10. Committee on Safety of Medicines. Reminder: lamotrigine (Lamictal) and serious skin reactions. Curr Probl Pharmacovigilance 1996;22:12.
11. Price E, Venables P. Drug-induced lupus. Drug Safety 1995;12(4):283-90.
12. Brodie M. Established anticonvulsants and treatment of refractory epilepsy. Lancet 1990;336:350-4.
13. Hawkins D. Epilepsy: protecting the mother and her baby. Prescriber 1996;7(10):19-24.